Navigation Links
Edwards Lifesciences to Host Earnings Conference Call on February 5, 2008
Date:1/29/2008

IRVINE, Calif., Jan. 29 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: EW), a global leader in products and technologies to treat advanced cardiovascular disease, plans to announce its operating results for the quarter ended December 31, 2007 after the market closes on Tuesday, February 5, 2008 and will host a conference call at 5:00 p.m. ET that day to discuss its results.

To participate in the conference call, dial (877) 407-8037 or (201) 689-8037. For 72 hours following the call, an audio replay can be accessed by dialing (877) 660-6853 or (201) 612-7415 and using account number 2995 and conference number 270419. The call will also be available via live or archived webcast on the "Investor Relations" section of the Edwards web site at http://www.edwards.com or http://www.edwards.com/InvestorRelations/EventCalendar.htm.

About Edwards Lifesciences

Edwards Lifesciences, a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular disease states including heart valve disease, vascular disease and critical care technologies. The company's global brands, which are sold in approximately 100 countries, include Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional company information can be found at http://www.edwards.com.

Edwards is a trademark of Edwards Lifesciences Corporation. Edwards Lifesciences, Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the U.S. Patent and Trademark Office.


'/>"/>
SOURCE Edwards Lifesciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Edwards Lifesciences Receives FDA Approval to Add Transapical Delivery System to U.S. Clinical Trial of Transcatheter Heart Valve
2. Edwards Lifesciences Completes Acquisition of CardioVations Product Line
3. Edwards Lifesciences Forecasts Strong Growth in 2008
4. Marshall Edwards, Inc. to Present at BIO Investor Forum 2007
5. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
6. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
7. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
8. Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
9. Barr Will Host Calendar 2007 and Fourth Quarter Earnings Conference Call on February 28, 2008
10. Sigma-Aldrich Corporations 4th Quarter 2007 Earnings Conference Call
11. Gen-Probe Announces Webcast of Fourth Quarter and Full Year 2007 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... March 22, 2017   Boston Biomedical , an ... designed to target cancer stemness pathways, today announced its ... as Chief Executive Officer, effective April 24, 2017. ... J. Li , M.D., FACP, who has led Boston ... Under his leadership, Boston Biomedical has grown from a ...
(Date:3/22/2017)... ... , ... Okyanos Cell Therapy has announced Tallahassee, FL will be the next ... Cell Therapy: The Next Phase in the Evolution of Medicine.” As the Bahamas’ first ... Therapy Act, Okyanos maintains a mission to help “no-option” patients and those with ...
(Date:3/22/2017)... ... March 21, 2017 , ... Aqua Design Innovations (ADI) has ... raising over $30,000 in the first 40 minutes of crowdfunding. EcoQube is a ... easy, and affordably, anywhere. , “Simply add fertilized water and in less than ...
(Date:3/22/2017)... ... March 21, 2017 , ... Functional near-infrared spectroscopy (fNIRS), an optical imaging tool ... way to track the brain’s response to acute pain in adults and infants. , ... ,” published today in the journal Neurophotonics , by SPIE, the international ...
Breaking Biology Technology:
(Date:3/2/2017)... LONDON , March 2, 2017 Summary ... require to better understand Merck KGaA and its partnering ... report: https://www.reportbuyer.com/product/3605601/ Description The Partnering Deals ... into the partnering activity of one of the world,s ... reports are prepared upon purchase to ensure inclusion of ...
(Date:2/28/2017)... 28, 2017 News solutions for biometrics, bag ... ... from 14 to 16 March, Materna will present its complete ... seamless travel is a real benefit for passengers. To accelerate ... their passenger touch point solutions to take passengers through the complete ...
(Date:2/22/2017)... , Feb. 22, 2017 With ... 2021, ABI Research identifies four technologies that innovative ... to secure significant share in the changing competitive ... and passive authentication.   "Companies can ... comes to security," says Dimitrios Pavlakis , ...
Breaking Biology News(10 mins):